When people with obesity who already have weight-related illness lose weight, it reduces their risk of developing further health complications due to their obesity
Then again, as Hicks notes, some influencers who were previously plus-size have moved into the midsize category after taking GLP-1s
Colleen McCabe, PharmD, BCOP, and Lindsay Mundy, PharmD, BCOP, led an engaging exploration of the benefits and potential pitfalls with the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in an oncology setting in their presentation, GLP-1s in Oncology: Miracle, Misdirection, or Missed Opportunity
Note: All peptide products are for research purposes only
Safety, FDA Enforcement, and Pharmacy Credentials The February 2026 FDA warning letter to MEDVi made headlines
Viral depletion of calcitonin receptors in the area postrema: a proof-of-concept study